Should hydroxyethyl starch solutions be totally banned?

The choice of which intravenous solution to prescribe remains a matter of considerable debate in intensive care units around the world. Trends have been moving away from using hydroxyethyl starch solutions following concerns about safety. But are the available data sufficient to clearly assess the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincent, Jean-Louis, Kellum, John A, Shaw, Andrew, Mythen, Michael G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871763/
https://www.ncbi.nlm.nih.gov/pubmed/24083341
http://dx.doi.org/10.1186/cc13027
_version_ 1782296877556826112
author Vincent, Jean-Louis
Kellum, John A
Shaw, Andrew
Mythen, Michael G
author_facet Vincent, Jean-Louis
Kellum, John A
Shaw, Andrew
Mythen, Michael G
author_sort Vincent, Jean-Louis
collection PubMed
description The choice of which intravenous solution to prescribe remains a matter of considerable debate in intensive care units around the world. Trends have been moving away from using hydroxyethyl starch solutions following concerns about safety. But are the available data sufficient to clearly assess the risk-benefit balance for all patients, and is there enough evidence of harm to justify removing these drugs completely from our hospitals?
format Online
Article
Text
id pubmed-3871763
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38717632014-10-01 Should hydroxyethyl starch solutions be totally banned? Vincent, Jean-Louis Kellum, John A Shaw, Andrew Mythen, Michael G Crit Care Commentary The choice of which intravenous solution to prescribe remains a matter of considerable debate in intensive care units around the world. Trends have been moving away from using hydroxyethyl starch solutions following concerns about safety. But are the available data sufficient to clearly assess the risk-benefit balance for all patients, and is there enough evidence of harm to justify removing these drugs completely from our hospitals? BioMed Central 2013 2013-10-01 /pmc/articles/PMC3871763/ /pubmed/24083341 http://dx.doi.org/10.1186/cc13027 Text en Copyright © 2013 BioMed Central Ltd.
spellingShingle Commentary
Vincent, Jean-Louis
Kellum, John A
Shaw, Andrew
Mythen, Michael G
Should hydroxyethyl starch solutions be totally banned?
title Should hydroxyethyl starch solutions be totally banned?
title_full Should hydroxyethyl starch solutions be totally banned?
title_fullStr Should hydroxyethyl starch solutions be totally banned?
title_full_unstemmed Should hydroxyethyl starch solutions be totally banned?
title_short Should hydroxyethyl starch solutions be totally banned?
title_sort should hydroxyethyl starch solutions be totally banned?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871763/
https://www.ncbi.nlm.nih.gov/pubmed/24083341
http://dx.doi.org/10.1186/cc13027
work_keys_str_mv AT vincentjeanlouis shouldhydroxyethylstarchsolutionsbetotallybanned
AT kellumjohna shouldhydroxyethylstarchsolutionsbetotallybanned
AT shawandrew shouldhydroxyethylstarchsolutionsbetotallybanned
AT mythenmichaelg shouldhydroxyethylstarchsolutionsbetotallybanned

Ejemplares similares